Schedule 13G ownership disclosure
Silence Therapeutics plc
Security class unavailable · CUSIP: 9EQ35FLN6
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,828,417
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000769993-22-000058
- Form type
- SC 13G
- Filer
- GOLDMAN SACHS GROUP INC
- CIK
- CIK 886982
- Filed
- Jan 27, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership